Skip to main content
ILIKA PLC logo

ILIKA PLC — Investor Relations & Filings

Ticker · IGE ISIN · GB00B608Z994 LEI · 213800TMDNIE3Z8XXD26 IL Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2017-06-22 Report Publication Anno…
Country GB United Kingdom
Listing IL IGE

About ILIKA PLC

https://www.ilika.com/

Ilika PLC is a pioneer in the development and manufacturing of solid-state battery (SSB) technology. The company's portfolio is centered on two product lines: Stereax® micro-batteries and Goliath large-format batteries. Stereax® batteries are miniaturized, millimeter-scale power sources designed for applications in MedTech, such as active implanted medical devices, and for Industrial Internet of Things (IIoT) sensors. The Goliath product line is focused on developing large-format cells for the electric vehicle (EV) market. These batteries are engineered to be a safer alternative to conventional EV batteries, with the potential to deliver extended range and faster charging capabilities. Ilika's core SSB technology emphasizes safety, non-flammability, and long cycle and storage life.

Recent filings

Filing Released Lang Actions
Investor results briefing
Report Publication Announcement Classification · 99% confidence The document is a short announcement (1920 chars) disseminated via RNS (RNS Number : 8041I) from Ilika plc. The core content is announcing an 'Investor results briefing' scheduled for July 11, 2017, where management will present financial and operational results for the year ended April 30, 2017. This is not the full results report itself (like 10-K or IR), but rather an announcement about a presentation event where results will be discussed. This fits the definition of a Report Publication Announcement (RPA) as it announces the timing and nature of a presentation covering results, or potentially a general Regulatory Filing (RNS) if the primary purpose is the announcement mechanism itself. Given the specific nature of announcing a presentation event for investors regarding results, RPA is a strong candidate, but since it is explicitly distributed via RNS and is an announcement about future events/presentations rather than the publication of a formal statutory report, RNS (Regulatory Filings) serves as a robust classification for this type of market notice, especially when the content is focused on the logistics of an investor event.
2017-06-22 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is very short (1644 characters) and explicitly states that the company 'will announce its Preliminary Results for the year ended 30 April 2017 on Tuesday 11 July 2017.' It also mentions an analyst briefing. This structure—announcing the future release date of a report (Preliminary Results, which are similar to an Interim Report or Earnings Release) rather than containing the full report itself—fits the definition of a Report Publication Announcement (RPA). It is not the full 10-K, IR, or ER, but the notice *about* the upcoming release.
2017-06-14 English
Product Enhancement
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated April 26, 2017. The content announces a 'Product Enhancement' and the 'Launch of StereaxTM P180 solid-state battery'. The closing line explicitly states, 'This information is provided by RNS The company news service from the London Stock Exchange'. This structure and explicit source identification strongly indicate a general regulatory announcement disseminated via the Regulatory News Service (RNS). Since the announcement is about a product launch and not a financial report (like 10-K, ER, IR), a management change (MANG), or a specific shareholder vote result (DVA), the most appropriate classification is the general regulatory filing category.
2017-04-26 English
Further information on TRI collaboration
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement. The content describes an update regarding a collaboration between Ilika plc and Toyota Research Institute (TRI) concerning materials science and battery technology. This is not a full financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). It is a specific corporate announcement regarding a partnership/development, which is best categorized as a general regulatory filing or announcement that doesn't fit the more specific categories like M&A (TAR) or Capital Change (CAP). Since it is explicitly marked with an RNS number and is a general corporate update, the most appropriate fallback category is Regulatory Filings (RNS). The document length is moderate (5734 chars), but the content is purely informational news release style, not a formal report.
2017-03-30 English
Patent grant for solid-state batteries in USA
Regulatory Filings Classification · 98% confidence The document is identified by the header 'RNS Number : 2632A' and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. This indicates it is a general regulatory announcement. The content specifically discusses the granting of a patent ('Patent grant for solid-state batteries in USA') and related intellectual property (IP). While it relates to IP, it is structured as a broad, immediate regulatory update rather than a formal legal filing (LTR) or a dedicated investor presentation (IP). Given the structure as an RNS announcement covering a specific corporate event (patent grant), the most appropriate general category for immediate regulatory news that doesn't fit a more specific financial report type is 'Regulatory Filings' (RNS).
2017-03-23 English
Replacement: Trading update
Earnings Release Classification · 99% confidence The document begins with an 'RNS Number' header and explicitly states, 'RNS Number : 8736Z'. It is an update to a previously released 'Trading update' announcement. The content discusses revenue expectations, product roadmaps (Stereax), and material development programs, which are typical elements of an Earnings Release (ER) or a Management Discussion & Analysis (MDA). However, the document is explicitly identified as an RNS release, and the content itself is a trading update providing key financial highlights and operational progress, rather than a full, comprehensive report (like a 10-K or IR). Since it is a formal announcement disseminated via the Regulatory News Service (RNS) system, and it contains operational and financial highlights, it fits best as an Earnings Release (ER) or potentially a general Regulatory Filing (RNS). Given the content focuses on trading performance ('Revenue update', 'Trading update'), ER is a strong candidate. However, the primary identifier is the RNS header and the nature of the release being a correction/amendment to a prior RNS announcement. Since the content is a trading update (financial highlights), ER is more specific than RNS. I will classify it as ER, as it is an initial announcement of period performance highlights, even though it is distributed via RNS. FY 2017
2017-03-17 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.